FDA NDC Directory · JSON-LD · Markdown

EMFLAZA

NDC 52856-505 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namedeflazacort
Labeler / ManufacturerPTC Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208685
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDEFLAZACORT (22.75 mg/mL)
Marketing started20180910
Package count1

External sources

Source: openFDA. Public-domain (CC0).